Staar Surgical AquaFlow Glaucoma Drainage Device Approvable - FDA Panel

Staar Surgical should collect expanded two-year follow-up data for patients treated with the AquaFlow collagen glaucoma drainage device as a condition of FDA approval, the agency's Ophthalmic Devices Advisory Panel recommended Nov. 8 in Gaithersburg, Maryland.

More from Archive

More from Medtech Insight